Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA Internal Medicine

Topics

Medicine

Cancer Oncology

Internal Medicine

Pharmacology

Covid-19

Show all topics

DOI

10.1001/jamainternmed.2021.6203